Volume 16, Issue 3, March 2024

Review

Regulation of m6Am RNA modification and its implications in human diseases
Hao Jin, Zhouyuanjing Shi, Tianhua Zhou, Shanshan Xie
J Mol Cell Biol, Volume 16, Issue 3, March 2024, mjae012, https://doi.org/10.1093/jmcb/mjae012
Abstract | Full Text 

Articles

Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern 
Ilaria Frasson, Linda Diamante, Manuela Zangrossi, Elena Carbognin, Anna Dalla Pietà, Alessandro Penna, Antonio Rosato, Ranieri Verin, Filippo Torrigiani, Cristiano Salata, Marìa Paula Dizanzo, Lorenzo Vaccaro, Davide Cacchiarelli, Sara N. Richter, Marco Montagner, Graziano Martello
J Mol Cell Biol, Volume 16, Issue 3, March 2024, mjae004, https://doi.org/10.1093/jmcb/mjae004
Abstract | Full Text 
Discovery of Trametinib as an orchestrator for cytoskeletal vimentin remodeling
Shuangshuang Zhao, Zhifang Li, Qian Zhang, Yue Zhang, Jiali Zhang, Gaofeng Fan, Xiaobao Cao, Yaming Jiu
J Mol Cell Biol, Volume 16, Issue 3, March 2024, mjae009, https://doi.org/10.1093/jmcb/mjae009
Abstract | Full Text 
Metabolomic profiling reveals decreased serum cysteine levels during gestational diabetes mellitus progression
Mengyu Lai, Jiaomeng Li, Jiaying Yang, Qingli Zhang, Yujia Gong, Yuhang Ma, Fang Fang, Na Li, Yingxiang Zhai, Tingting Shen, Yongde Peng, Jia Liu, Yufan Wang
J Mol Cell Biol, Volume 16, Issue 3, March 2024, mjae010, https://doi.org/10.1093/jmcb/mjae010
Abstract | Full Text 
Telomeric DNA breaks in human induced pluripotent stem cells trigger ATR-mediated arrest and telomerase-independent telomere damage repair 
Katrina N. Estep, John W. Tobias, Rafael J. Fernandez, Brinley M. Beveridge, F. Brad Johnson
J Mol Cell Biol, Volume 16, Issue 3, March 2024, mjad058, https://doi.org/10.1093/jmcb/mjad058
Abstract | Full Text 

Research Advance

Comments on ‘Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer
Xinyuan Tong, Ningxia Zhang, Yun Xue, Hongbin Ji
J Mol Cell Biol, Volume 16, Issue 3, March 2024, mjae013, https://doi.org/10.1093/jmcb/mjae013
Abstract | Full Text 
Cover: The small makes big. The stone-born monkey, indifferent from all the rest monkeys except for the phoenix-feather (indicative of the same pathology as lung adenocarcinoma but with minor difference in the expression of the squamous marker KRT6A), is able to challenge the crystal-clear Water Curtain Cave (indicative of resistance to adagrasib therapy in the KRYSTAL-1 clinical trial). See mjae013 by Tong et al. for details.